Search Results 401-410 of 16801 for GLP-1 agonists

  1. Neurofibromatosis type 1 - Doctors and departments - Mayo Clinic

    Mayo Clinic has one of the largest and most experienced practices in the United States, with campuses in Arizona, Florida and Minnesota. Staff skilled in dozens ...

  2. Neurofibromatosis type 1 - Doctors and departments - Mayo Clinic

    Mayo Clinic has one of the largest and most experienced practices in the United States, with campuses in Arizona, Florida and Minnesota. Staff skilled in dozens ...

  3. Plasminogen, human-tvmh (intravenous route) - Side effects & uses - Mayo Clinic

    Plasminogen, human-tvmh injection is used to treat plasminogen deficiency type 1 (hypoplasminogenemia). It works by increasing the plasminogen levels in the ...

  4. Exploratory Ph 2A, Double-Blind, Placebo-Controlled Dose Escalation Study of Safety, Tolerability, PD, & PK of HU6 for Subjects With Obese HFpEF - Mayo Clinic

    ... 1 trial. Phase 4 trials look at long-term safety and ... Treatment with GLP-1 receptor agonist begun within approximately 1 year of screening.

  5. Cyproterone (oral route, intramuscular route) - Side effects & dosage - Mayo Clinic

    This medicine blocks the effect of the male hormone testosterone in the body. This decreases the amount of testosterone produced in the body and is one way of ...

  6. Feasibility of a Wireless Patch System (WPS) to Measure Gastrointestinal Motility and Gastric Emptying - Mayo Clinic

    AAre on chronic opioids or other medications known to affect gastric emptying (e.g., GLP-1 agonists, high dose tricyclic agents). Have been recently ...

  7. Endocrinology - Doctors - Mayo Clinic

    Mayo Clinic has one of the largest and most experienced practices in the United States, with campuses in Arizona, Florida and Minnesota.

  8. Neurofibromatosis type 1 - Doctors and departments - Mayo Clinic

    Research. Mayo Clinic researchers study genetics, causes and new treatments for people with neurofibromatosis type 1. Research is conducted by Mayo Clinic ...

  9. Medicines that treat ulcerative colitis - Mayo Clinic

    TNF is one of the body's strongest signaling proteins. It acts like an alarm, telling the body to ramp up immune activity and inflammation. Blocking how TNF ...

  10. Phase 1/2 Dose Escalation Study in Patients With Relapsed or Refractory Waldenstrom's Macroglobulinemia - Mayo Clinic

    Recent reports have identified a specific oncogenic mutation L265P of the MYD88 gene in approximately 90% of the patients with Waldenström's macroglobulinemia.